An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia

Nor Hamizah Shafiee; Nurul Huda Razalli; Norfilza M. Mokhtar; Eunice Tan; Raja Affendi Raja Ali

doi:10.5217/ir.2020.00050

Articles

Page Path: HOME > Intest Res > Volume 20(1); 2022 > Article

Original Article An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia: Nor Hamizah Shafiee¹, Nurul Huda Razalli^2,3, Norfilza M. Mokhtar^3,4, Eunice Tan⁵, Raja Affendi Raja Ali^3,5,; Intestinal Research 2022;20(1):124-133.
DOI: https://doi.org/10.5217/ir.2020.00050
Published online: January 22, 2021

¹Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

²Dietetics Programme, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

³GUT Research Group, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

⁴Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

⁵Gastroenterology Unit, Department of Medicine, UKM Medical Centre, Kuala Lumpur, Malaysia

Correspondence to Raja Affendi Raja Ali, Gastroenterology Unit, Department of Medicine, UKM Medical Centre, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur 56000, Malaysia. Tel: +60-3-91456094, Fax: +60-3-91456692, E-mail: draffendi@ppukm.ukm.edu.my

• Received: May 15, 2020 • Revised: October 31, 2020 • Accepted: November 9, 2020

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

7,454 Views
329 Download
8 Web of Science
9 Crossref
8 Scopus

Full Article

Download PDF

Abstract
INTRODUCTION
METHODS
RESULTS
DISCUSSION
NOTES
REFERENCES

Abstract

Background/Aims
Substantial proportions of patients with constipation-predominant irritable bowel syndrome (IBS-C) linked their symptoms with particular intake of foods. However, there is lack of current data regarding the intake among IBS-C patients before any dietary interventions. Thus, this study aimed to evaluate the dietary adequacy among IBS-C against the standard recommended nutrient intake (RNI) and healthy controls.
Methods
A retrospective case-control study was conducted involving IBS-C patients and healthy control subjects. A validated 126-food items frequency questionnaire was administered to all the subjects to assess their dietary intake, guided by dietitians. The calculated nutrients intake for IBS-C patients was then compared against the standard RNI and healthy controls.
Results
A total of 306 subjects were recruited, among which 218 were diagnosed with IBS-C and 88 were included as healthy controls. IBS-C patients had significantly lower intake of wholegrain products, fried foods, dairy products, fruits, and vegetables compared to healthy controls. The daily intake of energy, certain macronutrients, and micronutrients among IBS-C patients was significantly lower than the healthy subjects. Less than 5% of IBS-C patients and healthy subjects achieved the standard recommendation for dietary fiber. Also, various vitamin intake (B₁, B₂, B₆, folate, B₁₂, E, K, and potassium) among IBS-C patients did not meet the standard RNI.
Conclusions
Dietary intakes of IBS-C patients did not meet the recommended intake for Malaysian and showed the nutritional inadequacies compared to the control subjects. Our study highlighted the importance of dietary evaluation prior to planning strategies for dietary intervention targeting IBS-C patients.
Keywords: Irritable bowel syndrome; Nutrients; Food; Nutritional requirement

INTRODUCTION

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal (GI) disorder characterized by abdominal pain associated with irregular bowel movement and stool consistency with the absence of organic causes [1]. Patients with IBS are subdivided into constipation-predominant (IBS-C), diarrheapredominant, and mixed patterns constipation and diarrhea [2]. The worldwide prevalence of IBS ranges between 3% and 22% of the population and approximately one-third of IBS patients suffered from IBS-C [3-6]. In Malaysia, IBS was reported affecting about 15% of the population, with the higher prevalence rate predominantly observed in women [7].

Despite the high prevalence rate, the exact pathogenesis of IBS-C is still uncertain, thus the management approach is mainly targeted on the associated symptoms to improve patient’s quality of life. However, to date, no single drug regimen is effective for the long-term efficacy of the patients’ specific symptoms and there are also significant rates of the associated adverse effects [8]. Therefore, many IBS-C patients opt for an alteration in their diet as a therapeutic strategy. Several studies have proven the beneficial effects of low fermentable oligo-, di-, and mono-saccharides and polyols (FODMAPs), limitation of gasproducing foods, gluten-free diet, dietary fiber supplementation, and/or consumptions of probiotics as a nutrition-based therapy to improve IBS-C patient outcomes [9-14].

Approximately two-thirds of IBS-C patients believe that diet or certain types of foods may trigger or exacerbate their range of digestive symptoms thus, making nutrition therapy the main therapeutic approach in the management of patients [15,16]. Among the IBS-C patients, food rich in carbohydrates, lactose-containing foods, fatty foods, caffeinated drinks, hot spices, and alcohol were affiliated with digestive symptoms such as abdominal pain and bloating [17]. However, the complexity of the food composition, making it harder to identify the specific food items involved in the onset or worsening of the IBS-C symptoms [18]. Therefore, patients tend to excessively practice the dietary restrictions that may lead to a high risk of long-term nutritional inadequacies.

Despite diet and food have been proposed to play a pivotal role in the management of IBS-C [19], relatively few studies been conducted to examine thoroughly the habitual dietary intake among IBS-C patients. Moreover, little is known regarding the dietary adequacy of IBS-C patients before any dietary interventions. Thus, this study aimed to evaluate the dietary intake, macro and micronutrients adequacy among IBS-C against the standard recommended nutrient intake (RNI) and healthy controls.

METHODS

1. Patient’s Selection

A retrospective case-control study was conducted at the gastroenterology outpatient clinics and endoscopic daycare in a tertiary medical center in Kuala Lumpur, Malaysia. Data were collected between April 2018 and April 2019. Adult patients aged 18 years and above with the diagnosis of IBS-C that fulfilled all the recommendations established by Rome IV criteria (diagnostic criteria for functional gastrointestinal disorders) [20] were recruited. To differentiate the IBS-C group from regular constipation patients, the diagnosis was largely based on the history of the symptoms reported by patients. These may include tracking the symptoms of constipation, along with the timing and severity of abdominal pain. IBS-C brings about intense abdominal pain compared to regular constipation. Those subjects without any functional disorder by Rome IV were included as healthy controls. Healthy controls were subjects that were randomly chosen from the staff and employees at the tertiary medical center. All the subjects were screened for eligibility by a gastroenterologist. IBS-C patients and control subjects were excluded if they had any preexisting organic or metabolic disorder (autoimmune disease, any type of malignancies, chronic inflammatory disease, infectious disease, malabsorption syndrome, and diabetes mellitus). Those who consumed antibiotics, probiotics, and/or laxatives less than 6 weeks before the recruitment were excluded. Those who were pregnant and lactating were also excluded. Those who met the criteria were given an information sheet and written informed consent was obtained from all the subjects on enrolment. The Universiti Kebangsaan Malaysia Medical and Research Ethics Committee (UKMREC; approval No. FF-2017-214) granted ethical approval of this study.

2. Dietary Intake Assessment

Dietary intake of all the IBS-C patients and healthy control subjects was assessed retrospectively using a validated food frequency questionnaire (FFQ) [21] which was adapted from the Malaysian Adult Nutrition Survey FFQ. This dietary assessment method was developed to evaluate the long-term habitual dietary intake of the subjects over the past year. The FFQ was formatted and included the detailed instructions and guidelines for the interviewer so that the information on the usual intake could be obtained using non-leading and open-ended questions. The 126-food items listed in the FFQ were categorized into 15 food groups, namely: cereal and cereal products, cooked rice and noodles, traditional kueh, desserts and confectionery, meat and poultry, internal organs, fish and shellfish, legumes, vegetables, fruits, milk and dairy products, jam and spread, beverages, sauces and condiments, and fast-foods. Malaysian meals were different compared to Western meals. Malaysian meal items listed in this FFQ reflect the multi-ethnic society of Malaysia sharing diverse food cultures. In general, most Malaysian meals are either based on rice or noodle dishes that are commonly consumed as the daily source of carbohydrate [22], accompanied with a variety of side dishes or lauk that consist of protein-based foods such as meat, egg, fish, and/or seafood dishes as well as vegetable dishes [23]. Meanwhile, when considering the Western meals in general, red meat is the most consumed food item, e.g., steaks or cutlets are the most preferred dishes across the West. Besides, the portion size of Western meals tends to be bigger compared to Malaysian meals.

The FFQ was administered through a one-to-one interview where subjects were requested to provide the type of normally consumed food items, the frequency of intake, the portion size, and the number of serving sizes consumed each time either per day, per week, per month, per year or never, guided by a dietitian. The subject was required to answer only one option. To minimize errors while assessing the dietary intake of subjects, the interview process was started by asking the subject to recall all of the food items that were usually consumed daily and the recall process was built up during a period of weeks and months. The household measurements that were available in the Atlas of Food Exchanges and Portion Sizes [24], such as a cup, matchbox size, small bowl, and spoons, were used to help better quantify the portion size. This FFQ also included questions on preparation methods for the related food items listed. Completed FFQs were then re-checked by a dietitian for completeness and accuracy.

The frequencies of the food intake in the FFQ had then been translated into the amount of food intake using the devised formula by Wessex Institute of Public Health University of Southampton, 1995; according to the following equation [25].

Weight of the food (g) per day = frequency of food intake (conversion factor) × serving size × number of serving × weight of food in one serving (g)

The 4th edition of Nutrition Composition of Malaysian Foods [26] was also used as a reference for accurate analysis of the data. From the amount of food taken per day, the detailed nutrient intake analysis was calculated using the Nutritionist Pro^TM Diet Analysis (Axxya Systems, Woodinville, WA, USA) software. The calculated data of nutrients intake were analyzed against the RNI for Malaysian (RNI 2017) and were then compared with the healthy controls.

3. Statistical Methods

Data were compiled and analyzed using IBM Products and Service Solution (SPSS) Statistics version 23 (IBM Corp., Armonk, NY, USA). The distribution of all the variables was checked for normal and non-normally distributed variables using skewness and kurtosis and was later verified by using Kolmogorov-Smirnov test. No missing data was found in this study. All the normally distributed data were described as mean ± standard deviation (SD). Descriptive analyses were used to describe the frequencies and proportion (%) of all the quantitative data. Comparison of the continuous variables between IBS-C patients and healthy controls were analyzed using independent sample t-test. Chi-square test was performed for comparison of all the categorical variables. The significance level was set at P-value < 0.05.

RESULTS

1. Baseline Characteristics of IBS-C Patients and Healthy Control Subjects

A total of 306 subjects were participated in the study and completed the FFQ, among which 218 (71.2%) were diagnosed with IBS-C and 88 (28.8%) of the remaining subjects were included as the healthy controls. The enrolled numbers of IBS-C and controls were statistically appropriate. The detailed baseline characteristics of the study subjects were summarized in Table 1. The mean age for IBS-C patients and healthy control subjects were 31.32 years and 29.27 years, respectively. IBS-C patients and healthy subjects were comparable in age, gender, ethnicity, educational level, monthly income, and marital status (P>0.05).

2. Comparison of Daily Intake of Food Groups between

IBS-C Patients and Healthy Controls The comparison of the mean amount of food consumption between IBS-C patients and healthy controls were shown in Table 2. Compared with healthy subjects, patients with IBS-C had significantly lower consumption of wholegrain products (21.9 g/day vs. 40.1 g/day, P<0.001), fried or fatty foods (215.1 g/day vs. 270.3 g/day, P=0.004), dairy products (150.9 g/day vs. 231.9 g/day, P<0.001), fruits (57.0 g/day vs. 72.5 g/day, P<0.001) and vegetables (60.1 g/day vs. 91.8 g/day, P=0.021).

3. Comparison of Dietary Intake between IBS-C Patients and Healthy Control Subjects against the RNI for Malaysian (RNI 2017)

The mean (± SD) daily intake of energy, macronutrients, and selected micronutrients for the IBS-C patients and healthy control groups were presented in Table 3. The energy intake of IBS-C patients was significantly lower (1,631 ± 174 kcal) compared to healthy control subjects (1,959 ± 209 kcal) (P<0.001). As shown in Fig. 1, the actual intake of energy was 83.3% among the IBS-C patients and 96.5% in the healthy control subjects as compared with the Malaysian RNI. About 84% of IBS-C patients had achieved the recommendation for energy, whereas 97% of healthy control subjects achieved the standard energy requirement as shown in Fig. 2.

Among IBS-C patients, the intake of protein (71.4 ± 9.7 g) and fat (57.8 ± 5.1 g) was significantly lower than the intake of protein (81.4 ± 9.2 g) and fat (67.2 ± 8.0 g) of healthy subjects (P<0.001). However, when expressed as the percentage from total energy intake, these intakes did not differ significantly between the 2 groups. The total intakes of protein and fat were lower in both groups than recommendations, while the proportion of protein and fat were similar between the 2 groups. Daily total dietary fiber intake among the IBS-C patients (5.5 ± 1.6 g) was significantly lower than the intake of dietary fiber of healthy control subjects (10.7 ± 1.2 g) (P<0.001). However, both groups did not meet the RNI of 20–30 g/day. Less than 5% of the IBS-C patients and healthy subjects achieved the standard recommendation for dietary fiber.

Compared with healthy subjects, IBS-C patients had significantly lower daily intake of folate (116.6 ± 38.0 µg vs. 255.0 ± 84.0 µg, P<0.001), potassium (1.7 ± 0.3 mg vs. 3.4 ± 0.6 mg, P<0.001), vitamin B₆ (1.0 ± 0.2 mg vs. 1.1 ± 0.2 mg, P=0.032), vitamin D (0.8 ± 0.7 µg vs. 1.8 ± 1.2 µg, P<0.001), vitamin E (4.6 ± 1.6 µg vs. 5.7 ± 1.2 µg, P<0.001), and vitamin K (32.4 ± 23.2 µg vs. 41.5 ± 21.0 µg, P<0.001). However, the intake of zinc in IBS-C patients was significantly higher than in healthy subjects, (5.9 ± 1.8 mg vs. 3.8 ± 1.0 mg, P<0.001). As compared with RNI 2017, the intake of vitamins B₁, B₂, B₆, folate, B₁₂, E, K, and potassium in both groups did not meet the RNI for Malaysians. However, vitamin A and sodium intake among the IBS-C patients and healthy control subjects exceeded the RNI of 600 µg and 1,500 mg respectively.

DISCUSSION

In this study, both groups of IBS-C patients and healthy controls had reported eating a diet with macronutrients and micronutrients composition that did not meet the RNI for the Malaysian population. Also, the findings of the current study found that patients who were affected by IBS-C resulted in having poorer energy and nutrient intake as compared to healthy control subjects, possibly due to alteration or restriction of certain food items from their daily diet that might contribute to the nutritional deficiencies among these patients. Several studies have reported that IBS-C patients avoid different food items that strongly linked with their GI symptoms such as frequent episodes of gases and bloating, abdominal pain, and a feeling of incomplete evacuation [16,27]. However, poor understanding of dietary factors that exacerbate these symptoms possibly leads to the reduced intake of essential nutrients among IBS-C patients.

In this current study, we do not have the information on whether the patients have altered or restricted their diet due to symptoms or other reasons. However, as food and diet have appeared to be the pivotal roles in the generation of symptoms in most of the IBS-C patients [18], we hypothesized that patients with IBS-C often restrict some of the food groups as a way of coping with their disease. Moreover, it has been reported that almost 90% of patients willingly constrict their dietary intake with the aim to manage their symptoms [1,17]. As we compared this with a healthy population, some studies have reported that patients with IBS elicited their GI symptoms by one or more provocative dietary agents, such as carbohydrates, fatty foods, milk-based products, cruciferous vegetables, spicy foods, and coffee [15,16].

Therefore, this can deflect IBS-C patients to be more selective of their daily food choices. Many IBS patients restricted these provocative dietary components and some of them resulted in better GI symptoms, however, this potentially leads the patients to nutritional deficiencies or poorer quality diets [28]. While this current study has found nutritional inadequacies among IBS-C patients, a study among 104 IBS patients in the United Kingdom had shown contradicting results in which, the intake of energy and micronutrients (calcium, folate, vitamin B₁, and vitamin C) had significantly exceeded the reference nutrient intakes [29]. This is consistent with a previous study among 187 IBS patients in Sweden that demonstrated a significantly higher daily intake of vitamin E, folate, iron, and vitamin C [30]. Although certain food items exacerbate the IBS-C symptoms and the practice of exclusion diet is common, patients manage to manipulate their diet with nutrient-rich foods and not result in inadequate dietary intake.

Malaysian patients with IBS-C in this study demonstrated poor intake of dietary fiber as compared with the recommendation, which is a growing concern regarding the intake of vegetables, fruits, and wholegrain products which may also influence the daily intake of vitamins and minerals. Indeed, in this study, the IBS-C patients had a lower intake of vitamins B₁, B₂, B₆, folate, B₁₂, E, K, and potassium, which is in accordance with other studies [31,32]. In some IBS-C patients, intake of high dietary fiber may exacerbate the symptoms and can frequently cause abdominal pain, bloating, and distension [33,34]. The incomplete digested carbohydrate such as in vegetables (e.g., onions, asparagus, broccoli, cabbage, peas, and cauliflower) and fruits (e.g., prunes, plums, apple, and mango) may increase the intestinal luminal water content through the osmotic activity, which results in rapid gas production (e.g., hydrogen, methane, and carbon dioxide) and subsequent abdominal distention due to their fermentation by gut microbiota [35,36]. Besides, a higher dietary fiber consumption also provides benefits to IBS-C patients through an increase in the fecal bulk and quickening of the colonic transit time, which results in decreased water reabsorption and increases the stool weight [34,37]. Thus, the high fiber diet could act as a triggering factor for the GI symptoms or can be therapeutically useful in IBS-C management.

In recent decades, scientific evidence has emphasized the roles of dietary choices among IBS patients and diet manipulations as the potential treatment strategy. The British Dietetics Association (BDA, 2016) has provided the dietary algorithm for the clinical practices in the management of IBS, which emphasized what should be advised to these patients [14]. In this guideline, the first line of a dietary approach focusing on healthy eating and lifestyle which includes reducing the intake of alcohol, caffeine, spicy food, and fatty food, restriction of lactose-based products, and dietary fiber modification that can be offered by any healthcare professional [14].

The second line of dietary advice comprises the implementation of a diet with low FODMAP under the guidance of a dietitian [14]. Although there has been increasing evidence that intervention with low FODMAP diet ameliorates IBS symptoms, the efficacy, acceptance, and complexity of a low FODMAP diet among the Asian population remains uncertain especially in patients with IBS-C [38]. Generally, the usual food ingredients found in most of the Asian diet may include onion, garlic, shallots, legumes, and wheat-based products [38]. Due to distinct cultural and dietary habits of different major ethnic groups among the Malaysian population (e.g., Malay, Chinese, Indian, and indigenous groups), this has made it very difficult to specify and quantify the food items that exacerbate to symptoms of IBS [38].

In this study, IBS-C patients might follow these recommendations to decrease the symptoms by restricting some of the above-mentioned food items. For instance, in our study, IBS-C patients had reduced the number of certain food groups such as fried foods, thereby leading to a reduced intake of total energy and fat than healthy controls. Some studies have shown that duodenal lipids have increased the perception of rectal distension, which provides evidence of the restriction of fat intake in IBS-C patients [39,40]. However, most of the IBS-C patients often go to the extreme measure following dietary advice from these recommendations, and this leads to nutritionally deficient diets. In this study, a decreased fat intake may implicate the decrease in some of fat-soluble vitamins (e.g., vitamin D, E, and K). Also, the dietary advice of restriction of lactose-based products such as milk and dairy products in IBS-C may imply a decreased intake of calcium, potassium, vitamin B₁, B₂, B₆, B₁₂, D, E, and K which were consistent with some previous studies [16,29,30,41].

The results of this current study illustrated the need for a skilled dietitian who is knowledgeable in the dietary management of IBS, as clinicians may lack sufficient training in dietary skills and knowledge of food composition. Individualized dietary guidance is necessary to identify a suitable diet to which the patient is likely to adhere for a long-term [42]. However before embarking on the new diet plans, dietitians should explore the patient’s interest in making the dietary changes, take a dietary history, and assess the unusual food choices or dietary behavior as well as explore the patient’s ability to adopt a restricted diet [43]. A food diary kept by IBS patients can be a particularly helpful way to establish the potential “trigger foods” that exacerbate the symptoms. Dietitians, while working with patients suffering from IBS, should review the food diary and discuss the specific amounts of foods that are consumed and their relation to the patient’s overall symptoms [44]. This approach minimizes the unnecessary food restriction behavior which may be the cause of nutritional deficiencies and ensures that a maximum variety in the diet is achieved while significantly improving the symptoms [45]. As implementation and education of a specific restriction diet can be very challenging, dietitians need to educate the patients regarding the principle of diet together with suitable food alternatives to ensure the nutritional adequacy of an individual. Also, the role of a dietitian is important not only during the initial stages of establishing the dietary modification but is also integral in the subsequent step of gradual re-introduction to specific food components while evaluating their tolerance in the generation of symptoms, considering the specific food preferences and usual dietary habits [46].

Although seeing the dietitian repeatedly is likely crucial for the consistent success of the diet plan in IBS, but it would not always be achievable in the clinical settings, as it requires a highly motivated patient and this can be rather time-consuming. The adherence to the new diet plans also requires strenuous effort, therefore making it tiring and difficult for many IBS patients. A survey conducted in the United States has revealed that only a minority (21.0%) of gastroenterologists actually refer IBS patients to dietitians for nutritional counselling instead, they used the educational handouts to provide nutritional advice to their patients [47]. This is actually against the proper guidance to implement the complex dietary interventions especially for long-term success [48].

There are inherent limitations of using FFQ as a method of dietary assessment that should be acknowledged when interpreting the results. As this is a retrospective method where subjects were enquired to estimate their dietary intake for the previous year, therefore they may prone to recall bias. This questionnaire also solely relied on self-report, thus the food intake may be underreported or over-reported. In this study, we described a step-by-step guide to facilitate and improve the quality and accuracy of the dietary information collected. Throughout the guide, we made an effort to obtain accurate data and overcome the recall bias according to the study objective and subject’s characteristics. Dietary assessments such as food records or food diaries should be considered, as this prospective dietary method does not require the recall of foods and was much more accurate in assuming the amount of food consumed. In this present study, as we do not have the information regarding the reasons for dietary restriction/alteration, thus a detailed analysis of dietary intake is needed to further identify whether specific food items that are believed to aggravate the symptoms are avoided. A prospective study is needed to evaluate the relationship between the symptom’s severity and the changes in the nutritional consumption among IBS-C patients. This might influence the effectiveness of dietary manipulation as one of the therapeutic approaches in IBS-C management. In this study, the socioeconomic status of healthy controls tended to be better, compared with the IBS-C group especially regarding the monthly income of the control group, which tended to be higher (P=0.061). Therefore, it might explain why healthy controls were likely to select healthier food choices compared to IBS-C patients. In addition, the number of healthy controls was relatively small (28.8%) compared to IBS-C patients. It might be preferable to select more healthy subjects matched for socioeconomic status to further address the differences regarding their dietary intake. In this study, the healthy controls were selected as staff working in the tertiary medical center, leading to the potential of high selection bias to occur. It would be advantageous to select the control group among a general population to minimize the selection bias. Our study only covers patients with IBS-C, as the aim of this current study was solely to investigate the nutritional adequacy among IBS-C patients. Besides, we do not have the detailed information regarding the other subtypes of IBS including the data on the number (%) of patients attended the medical center. Because of this, we did not include the comparative dietary pattern analysis according to the subtypes of IBS. In this study, we also do not have detailed assessment of anthropometric measures (e.g., weight, body mass index, and waist circumference) although these factors were likely to have an impact on the dietary pattern of the enrolled subjects. Furthermore, we did not investigate whether there were subjects with other comorbidities (e.g., hypertension, diabetes mellitus, and cardiovascular disease), although it has been reported that IBS-C patients with comorbidities may have an impact on the clinical course of the disease. Our study also does not have the data regarding the frequency of alcohol drinking and smoking although it would be advantageous to analyze the differences of these factors between the 2 groups.

In conclusion, the findings of this study revealed that IBS-C patients consumed a diet that was deficient in macro- and micronutrients when compared against the standard RNI and healthy controls. Therefore, these dietary evaluations are needed to provide information for dietitians prior to devising planning strategies for dietary intervention targeting IBS-C patients. To succeed with dietary intervention, ongoing nutrition counselling should be provided by dietitians and a suitable diet should be recommended and adapted for every individual’s circumstances, as well as monitoring the progress and compliance of patients.

NOTES

Funding Source

The authors received no financial support for the research, authorship, and/or publication of this article.

Conflict of Interest

Ali RAR is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

Author Contribution

Conceptualization, methodology, formal analysis, and writing the original draft: Shafiee NH. Study supervision and critical revision of manuscript: Razalli NH, Mokhtar NM, Tan E, Ali RAR. Approval of final manuscript: all authors.

Fig. 1.

Nutrient intake in the constipation-predominant irritable bowel syndrome (IBS-C) patients and healthy control subjects in comparison against the recommended nutrient intake for Malaysian (RNI 2017); set to 100%.

Fig. 2.

Comparison of proportion of subjects that achieved the Malaysian recommended nutrient intake between constipation-predominant irritable bowel syndrome (IBS-C) patients and healthy control group.

Table 1.

Comparison of Baseline Characteristics between IBS-C Patients and Healthy Control Subjects

Baseline characteristics	IBS-C group (n = 218)	Healthy group (n = 88)	P-value
Age (yr)	31.32 ± 11.55	29.27 ± 7.64	0.127
Male sex			0.199
Male	77 (35.3)	38 (43.2)
Female	141 (64.7)	50 (56.8)
Ethnicity			0.108
Malay	150 (68.8)	72 (81.8)
Chinese	64 (29.4)	16 (18.2)
Indian	2 (0.9)	0
Others	2 (0.9)	0
Marital status			0.233
Single	111 (50.9)	51 (58.0)
Married	102 (46.8)	37 (42.0)
Divorce	5 (2.3)	0
Educational level			0.120
Primary	7 (3.2)	0
Secondary	42 (19.3)	28 (31.8)
Tertiary	169 (77.5)	60 (68.2)
Monthly income^a			0.061
< 1,500 RM	100 (45.9)	43 (48.9)
1,500–5,000 RM	101 (46.3)	26 (29.5)
> 5,000 RM	17 (7.8)	19 (21.6)
Employment status			0.521
Employed	133 (61.0)	50 (56.8)
Unemployed	85 (39.0)	38 (43.2)

Values are presented as mean±standard deviation or number (%).

^a (1 USD=RM 4.19).

IBS-C, constipation-predominant irritable bowel syndrome.

Table 2.

Comparison of Average Amount of Dietary Intake (g/day) between IBS-C Patients and Healthy Controls Subjects According to Food Groups

Food groups (g/day)	IBS-C group (n = 218)	Healthy group (n = 88)	P-value
Cereals and cereal products (e.g., rice, noodles, breakfast cereal, others)	401.9 ± 51.3	408.0 ± 51.4	0.612
Wholegrain products (e.g., brown rice, wholegrain bread or biscuits, oatmeal, others)	21.9 ± 3.7	40.1 ± 5.5	< 0.001
Fried and fatty foods (e.g., deep fried chicken or fish, fries, nugget, fried traditional kueh, others)	215.1 ± 27.5	270.3 ± 28.1	0.004
Sweetened foods or beverages (e.g., cakes, carbonated drinks, chocolate drinks, cordial, coffee or tea with condensed milk, others)	53.7 ± 10.1	55.0 ± 11.1	0.142
Dairy products (e.g., milk, cheese, yogurt, ice cream, others)	150.9 ± 35.8	231.9 ± 30.7	< 0.001
Fruits (e.g., apples, pear, watermelon, mango, others)	57.0 ± 11.0	72.5 ± 15.9	< 0.001
Vegetables (e.g., cabbage, cauliflower, mushrooms, garlic, others)	60.1 ± 8.9	91.8 ± 13.9	0.021
Processed foods (e.g., pizza, burgers, others)	31.3 ± 8.7	30.5 ± 8.5	0.079

Values are presented as mean±standard deviation.

IBS-C, constipation-predominant irritable bowel syndrome.

Table 3.

Comparison of Daily Energy, Macro and Micronutrients Intake between IBS-C Patients and Healthy Control Subjects

Nutrients	IBS-C group (n = 218)	Healthy group (n = 88)	P-value
Energy (kcal)	1,631.0 ± 174.0	1,959.0 ± 208.0	< 0.001
Protein (g)	71.4 ± 9.7	81.4 ± 9.2	< 0.001
% of calorie	17.5 ± 1.1	16.6 ± 1.2	0.245
Fat (g)	57.8 ± 5.1	67.2 ± 8.0	< 0.001
% of calorie	31.9 ± 2.5	30.9 ± 2.4	0.366
Carbohydrate (g)	206.4 ± 16.4	210.1 ± 11.3	0.058
% of calorie	50.6 ± 2.7	52.5 ± 2.8	0.135
Dietary fiber (g)	5.5 ± 1.6	10.7 ± 1.2	< 0.001
Cholesterol (mg)	225.5 ± 57.9	233.3 ± 55.5	0.114
Calcium (mg)	480.7 ± 156.2	621.4 ± 115.3	0.023
Folate (µg)	116.6 ± 38.0	255.0 ± 84.0	< 0.001
Iron (mg)	16.5 ± 4.0	15.7 ± 4.2	0.112
Zinc (mg)	5.9 ± 1.8	3.8 ± 1.0	< 0.001
Potassium (mg)	1.7 ± 0.3	3.4 ± 0.6	< 0.001
Sodium (mg)	1,909.4 ± 399.6	1,824.9 ± 189.4	0.059
Vitamin A (µg)	888 ± 189	902 ± 182	0.290
Vitamin B₁ (mg)	0.8 ± 0.2	0.9 ± 0.2	0.084
Vitamin B₂ (mg)	1.0 ± 0.2	1.0 ± 0.2	0.114
Vitamin B₆ (mg)	1.0 ± 0.2	1.1 ± 0.2	0.032
Vitamin B₁₂ (µg)	3.0 ± 1.0	2.9 ± 0.5	0.110
Vitamin C (mg)	57.2 ± 19.6	58.1 ± 18.7	0.723
Vitamin D (µg)	0.8 ± 0.7	1.8 ± 1.2	< 0.001
Vitamin E (µg)	4.6 ± 1.6	5.7 ± 1.2	< 0.001
Vitamin K (µg)	32.4 ± 23.2	41.5 ± 21.0	< 0.001

Values are presented as mean±standard deviation. The comparison of daily nutrients intake were compared according to the Malaysian recommended nutrient intake for Malaysian (RNI 2017).

IBS-C, constipation-predominant irritable bowel syndrome.

REFERENCES

1. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA 2015;313:949–958.Article PubMed
2. Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005;100:896–904.Article PubMed
3. Basandra S, Bajaj D. Epidemiology of dyspepsia and irritable bowel syndrome (IBS) in medical students of northern India. J Clin Diagn Res 2014;8:JC13–JC16.Article PubMed PMC
4. Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J Gastroenterol Hepatol 2010;25:691–699.Article PubMed
5. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712–721.Article PubMed
6. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108–2131.Article PubMed
7. Tan YM, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students. J Gastroenterol Hepatol 2003;18:1412–1416.Article PubMed
8. Bensoussan A, Kellow JE, Bourchier SJ, et al. Efficacy of a Chinese herbal medicine in providing adequate relief of constipation-predominant irritable bowel syndrome: a randomized controlled trial. Clin Gastroenterol Hepatol 2015;13:1946–1954.Article PubMed
9. Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:707–717.Article PubMed
10. Zhu Y, Zheng X, Cong Y, et al. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol 2013;108:1516–1525.Article PubMed
11. Vazquez-Roque MI, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013;144:903–911.Article PubMed
12. Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther 2015;41:1256–1270.Article PubMed
13. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol 2015;21:3072–3084.Article PubMed PMC
14. McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:549–575.Article PubMed
15. Simrén M, Månsson A, Langkilde AM, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001;63:108–115.Article
16. Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013;108:634–641.Article PubMed
17. Hayes PA, Fraher MH, Quigley EM. Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y) 2014;10:164–174.PubMed PMC
18. Cuomo R, Andreozzi P, Zito FP, Passananti V, De Carlo G, Sarnelli G. Irritable bowel syndrome and food interaction. World J Gastroenterol 2014;20:8837–8845.PubMed PMC
19. Torres MJ, Sabate JM, Bouchoucha M, Buscail C, Hercberg S, Julia C. Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study. Therap Adv Gastroenterol 2018;11:1756283X17746625.Article PubMed PMC
20. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology 2016;150:1393–1407.Article
21. Ministry of Health Malaysia, Nutrition Section, Family Health Development Division. Malaysian Adult Nutrition Survey 2003: Methodology. Putrajaya: Ministry of Health Malaysia, 2008.
22. Leong-Salobir C. Food culture in colonial Asia: a taste of empire. Hoboken: Taylor & Francis, 2011.
23. Raji MNA, Ab Karim S, Ishak FAC, Arshad MM. Past and present practices of the Malay food heritage and culture in Malaysia. J Ethn Food 2017;4:221–231.Article
24. Suzana S, Noor Aini MY, Nik Shanita S, Rafidah G, Roslina A. Atlas of food exchanges and portion sizes. 2nd ed. Kuala Lumpur: MDC Publishers, 2009.
25. Norimah AK Jr, Safiah M, Jamal K, et al. Food consumption patterns: findings from the Malaysian Adult Nutrition Survey (MANS). Malays J Nutr 2008;14:25–39.PubMed
26. Tee ES, Mohd Ismail N, Mohd Nasir A, Khatijah I. Nutrients composition of Malaysian foods. 4th ed. Kuala Lumpur: Malaysian Food Composition Database Programme c/o Institute for Medical Research, 1997.
27. Gibson PR. Food intolerance in functional bowel disorders. J Gastroenterol Hepatol 2011;26 Suppl 3:128–131.Article PubMed
28. Mullin GE, Shepherd SJ, Chander Roland B, Ireton-Jones C, Matarese LE. Irritable bowel syndrome: contemporary nutrition management strategies. JPEN J Parenter Enteral Nutr 2014;38:781–799.Article PubMed PDF
29. Williams EA, Nai X, Corfe BM. Dietary intakes in people with irritable bowel syndrome. BMC Gastroenterol 2011;11:9.Article PubMed PMC
30. Böhn L, Störsrud S, Simrén M. Nutrient intake in patients with irritable bowel syndrome compared with the general population. Neurogastroenterol Motil 2013;25:23–30.Article PubMed
31. Stevenson C, Blaauw R, Fredericks E, Visser J, Stevenson S. Food avoidance in irritable bowel syndrome leads to a nutrition-deficient diet. South Afr J Clin Nutr 2014;27:25–30.Article
32. Faresjö A, Johansson S, Faresjö T, Roos S, Hallert C. Sex differences in dietary coping with gastrointestinal symptoms. Eur J Gastroenterol Hepatol 2010;22:327–333.Article PubMed
33. Moayyedi P, Quigley EM, Lacy BE, et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2014;109:1367–1374.Article PubMed
34. El-Salhy M, Ystad SO, Mazzawi T, Gundersen D. Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med 2017;40:607–613.Article PubMed PMC
35. Gibson PR. History of the low FODMAP diet. J Gastroenterol Hepatol 2017;32 Suppl 1:5–7.Article PubMed
36. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1366–1373.Article PubMed
37. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:718–727.Article PubMed
38. Wong Z, Mok CZ, Majid HA, Mahadeva S. Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome. JGH Open 2018;2:178–181.Article PubMed PMC
39. Feinle-Bisset C, Azpiroz F. Dietary lipids and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:737–747.Article PubMed
40. Simrén M, Abrahamsson H, Björnsson ES. Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors. Clin Gastroenterol Hepatol 2007;5:201–208.Article PubMed
41. Ostgaard H, Hausken T, Gundersen D, El-Salhy M. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep 2012;5:1382–1390.PubMed
42. El-Salhy M, Gundersen D. Diet in irritable bowel syndrome. Nutr J 2015;14:36.Article PubMed PMC
43. Dugum M, Barco K, Garg S. Managing irritable bowel syndrome: the low-FODMAP diet. Cleve Clin J Med 2016;83:655–662.Article PubMed
44. Ikechi R, Fischer BD, DeSipio J, Phadtare S. Irritable bowel syndrome: clinical manifestations, dietary influences, and management. Healthcare (Basel) 2017;5:21.Article PubMed PMC
45. Shepherd SJ, Halmos E, Glance S. The role of FODMAPs in irritable bowel syndrome. Curr Opin Clin Nutr Metab Care 2014;17:605–609.Article PubMed
46. Tuck C, Barrett J. Re-challenging FODMAPs: the low FODMAP diet phase two. J Gastroenterol Hepatol 2017;32 Suppl 1:11–15.Article PubMed
47. Lenhart A, Ferch C, Shaw M, Chey WD. Use of dietary management in irritable bowel syndrome: results of a survey of over 1500 United States Gastroenterologists. J Neurogastroenterol Motil 2018;24:437–451.Article PubMed PMC
48. Barrett JS. How to institute the low-FODMAP diet. J Gastroenterol Hepatol 2017;32 Suppl 1:8–10.Article PubMed

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Association between dietary vitamin E intake and constipation: NHANES 2005–2010
Junfeng Cai, Danqing Li, Ruijun Xie, Xiaoling Yu, Yuning Wu, Feng Sun, Chenxiong Zhang
Frontiers in Nutrition.2024;[Epub] CrossRef
Systematic review and meta-analysis of habitual intake of fermentable oligo-, di-, mono- saccharides and polyols in the general population and revisiting the low FODMAP diet concept
Yoghatama Cindya Zanzer, Stephan Theis
Journal of Functional Foods.2024; 112: 105914. CrossRef
A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome
Marlynna Sarkawi, Raja Affendi Raja Ali, Norhazlina Abdul Wahab, Norshafila Diana Abdul Rathi, Norfilza Mohd Mokhtar
Scientific Reports.2024;[Epub] CrossRef
An Asian perspective on irritable bowel syndrome
Kee Wook Jung, Seung-Jae Myung
Intestinal Research.2023; 21(2): 189. CrossRef
Adult‐onset megacolon with focal hypoganglionosis: A detailed phenotyping and prospective cohort study
Jiyoung Yoon, Kee Wook Jung, Nam Seok Ham, Jihun Kim, Yoon Suh Do, Seon Ok Kim, Sang Hyun Choi, Dong Wook Kim, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Yong Sik Yoon, Chan Wook Kim, Chang Sik Yu, Hwoon‐Yong Jung, S
Neurogastroenterology & Motility.2023;[Epub] CrossRef
Downregulated APOD and FCGR2A correlates with immune infiltration and lipid-induced symptoms of irritable bowel syndrome
Yamei Ran, Kangqi Wu, Chenglin Hu, Renzheng Liang, Li Zhang, Juan Xiao, Yongmei Peng, Wenjing Sun
Scientific Reports.2023;[Epub] CrossRef
Letter to the Editor: Survey-Based Analysis of Clinical Treatment Status of Irritable Bowel Syndrome in Korea: Suggestions for Future Research
Ji Young Chang
Journal of Korean Medical Science.2023;[Epub] CrossRef
Comments on Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
Kwang Woo Kim
Gut and Liver.2023; 17(6): 954. CrossRef
Correlation Between Zinc Nutritional Status with Serum Zonulin and Gastrointestinal Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome: A Case–Control Study
Mahsa Rezazadegan, Maryam Soheilipour, Mohammad Javad Tarrahi, Reza Amani
Digestive Diseases and Sciences.2022; 67(8): 3632. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia

Intest Res. 2022;20(1):124-133. Published online January 22, 2021

DOI: https://doi.org/10.5217/ir.2020.00050

XML Download

Figure

An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia

Fig. 1. Nutrient intake in the constipation-predominant irritable bowel syndrome (IBS-C) patients and healthy control subjects in comparison against the recommended nutrient intake for Malaysian (RNI 2017); set to 100%.

Fig. 2. Comparison of proportion of subjects that achieved the Malaysian recommended nutrient intake between constipation-predominant irritable bowel syndrome (IBS-C) patients and healthy control group.

Fig. 1.

Fig. 2.

An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia

Baseline characteristics	IBS-C group (n = 218)	Healthy group (n = 88)	P-value
Age (yr)	31.32 ± 11.55	29.27 ± 7.64	0.127
Male sex			0.199
Male	77 (35.3)	38 (43.2)
Female	141 (64.7)	50 (56.8)
Ethnicity			0.108
Malay	150 (68.8)	72 (81.8)
Chinese	64 (29.4)	16 (18.2)
Indian	2 (0.9)	0
Others	2 (0.9)	0
Marital status			0.233
Single	111 (50.9)	51 (58.0)
Married	102 (46.8)	37 (42.0)
Divorce	5 (2.3)	0
Educational level			0.120
Primary	7 (3.2)	0
Secondary	42 (19.3)	28 (31.8)
Tertiary	169 (77.5)	60 (68.2)
Monthly income^a			0.061
< 1,500 RM	100 (45.9)	43 (48.9)
1,500–5,000 RM	101 (46.3)	26 (29.5)
> 5,000 RM	17 (7.8)	19 (21.6)
Employment status			0.521
Employed	133 (61.0)	50 (56.8)
Unemployed	85 (39.0)	38 (43.2)

Food groups (g/day)	IBS-C group (n = 218)	Healthy group (n = 88)	P-value
Cereals and cereal products (e.g., rice, noodles, breakfast cereal, others)	401.9 ± 51.3	408.0 ± 51.4	0.612
Wholegrain products (e.g., brown rice, wholegrain bread or biscuits, oatmeal, others)	21.9 ± 3.7	40.1 ± 5.5	< 0.001
Fried and fatty foods (e.g., deep fried chicken or fish, fries, nugget, fried traditional kueh, others)	215.1 ± 27.5	270.3 ± 28.1	0.004
Sweetened foods or beverages (e.g., cakes, carbonated drinks, chocolate drinks, cordial, coffee or tea with condensed milk, others)	53.7 ± 10.1	55.0 ± 11.1	0.142
Dairy products (e.g., milk, cheese, yogurt, ice cream, others)	150.9 ± 35.8	231.9 ± 30.7	< 0.001
Fruits (e.g., apples, pear, watermelon, mango, others)	57.0 ± 11.0	72.5 ± 15.9	< 0.001
Vegetables (e.g., cabbage, cauliflower, mushrooms, garlic, others)	60.1 ± 8.9	91.8 ± 13.9	0.021
Processed foods (e.g., pizza, burgers, others)	31.3 ± 8.7	30.5 ± 8.5	0.079

Nutrients	IBS-C group (n = 218)	Healthy group (n = 88)	P-value
Energy (kcal)	1,631.0 ± 174.0	1,959.0 ± 208.0	< 0.001
Protein (g)	71.4 ± 9.7	81.4 ± 9.2	< 0.001
% of calorie	17.5 ± 1.1	16.6 ± 1.2	0.245
Fat (g)	57.8 ± 5.1	67.2 ± 8.0	< 0.001
% of calorie	31.9 ± 2.5	30.9 ± 2.4	0.366
Carbohydrate (g)	206.4 ± 16.4	210.1 ± 11.3	0.058
% of calorie	50.6 ± 2.7	52.5 ± 2.8	0.135
Dietary fiber (g)	5.5 ± 1.6	10.7 ± 1.2	< 0.001
Cholesterol (mg)	225.5 ± 57.9	233.3 ± 55.5	0.114
Calcium (mg)	480.7 ± 156.2	621.4 ± 115.3	0.023
Folate (µg)	116.6 ± 38.0	255.0 ± 84.0	< 0.001
Iron (mg)	16.5 ± 4.0	15.7 ± 4.2	0.112
Zinc (mg)	5.9 ± 1.8	3.8 ± 1.0	< 0.001
Potassium (mg)	1.7 ± 0.3	3.4 ± 0.6	< 0.001
Sodium (mg)	1,909.4 ± 399.6	1,824.9 ± 189.4	0.059
Vitamin A (µg)	888 ± 189	902 ± 182	0.290
Vitamin B₁ (mg)	0.8 ± 0.2	0.9 ± 0.2	0.084
Vitamin B₂ (mg)	1.0 ± 0.2	1.0 ± 0.2	0.114
Vitamin B₆ (mg)	1.0 ± 0.2	1.1 ± 0.2	0.032
Vitamin B₁₂ (µg)	3.0 ± 1.0	2.9 ± 0.5	0.110
Vitamin C (mg)	57.2 ± 19.6	58.1 ± 18.7	0.723
Vitamin D (µg)	0.8 ± 0.7	1.8 ± 1.2	< 0.001
Vitamin E (µg)	4.6 ± 1.6	5.7 ± 1.2	< 0.001
Vitamin K (µg)	32.4 ± 23.2	41.5 ± 21.0	< 0.001

Table 1. Comparison of Baseline Characteristics between IBS-C Patients and Healthy Control Subjects

Values are presented as mean±standard deviation or number (%).

(1 USD=RM 4.19).

IBS-C, constipation-predominant irritable bowel syndrome.

Table 2. Comparison of Average Amount of Dietary Intake (g/day) between IBS-C Patients and Healthy Controls Subjects According to Food Groups

Values are presented as mean±standard deviation.

IBS-C, constipation-predominant irritable bowel syndrome.

Table 3. Comparison of Daily Energy, Macro and Micronutrients Intake between IBS-C Patients and Healthy Control Subjects

Values are presented as mean±standard deviation. The comparison of daily nutrients intake were compared according to the Malaysian recommended nutrient intake for Malaysian (RNI 2017).

IBS-C, constipation-predominant irritable bowel syndrome.